RESUMEN
BACKGROUND: Venom-induced acute kidney injury (AKI) is a frequent complication of Bothrops snakebite with relevant morbidity and mortality. The aim of this study was to assess the effects of Schizolobium parahyba (SP) extract, a natural medicine with presumed anti-Bothrops venom effects, in an experimental model of Bothrops jararaca venom (BV)-induced AKI. METHODOLOGY: Groups of 8 to 10 rats received infusions of 0.9% saline (control, C), SP 2 mg/kg, BV 0.25 mg/kg and BV immediately followed by SP (treatment, T) in the doses already described. After the respective infusions, animals were assessed for their glomerular filtration rate (GFR, inulin clearance), renal blood flow (RBF, Doppler), blood pressure (BP, intra-arterial transducer), renal vascular resistance (RVR), urinary osmolality (UO, freezing point), urinary neutrophil gelatinase-associated lipocalin (NGAL, enzyme-linked immunosorbent assay [ELISA]), lactate dehydrogenase (LDH, kinetic method), hematocrit (Hct, microhematocrit), fibrinogen (Fi, Klauss modified) and blinded renal histology (acute tubular necrosis score). PRINCIPAL FINDINGS: BV caused significant decreases in GFR, RBF, UO, HcT and Fi; significant increases in RVR, NGAL and LDH; and acute tubular necrosis. SP did not prevent these changes; instead, it caused a significant decrease in GFR when used alone. CONCLUSION: SP administered simultaneously with BV, in an approximate 10â¶1 concentration, did not prevent BV-induced AKI, hemolysis and fibrinogen consumption. SP used alone caused a decrease in GFR.
Asunto(s)
Lesión Renal Aguda/tratamiento farmacológico , Bothrops/metabolismo , Fabaceae/química , Extractos Vegetales/uso terapéutico , Lesión Renal Aguda/inducido químicamente , Lesión Renal Aguda/fisiopatología , Lesión Renal Aguda/orina , Proteínas de Fase Aguda/orina , Animales , Biomarcadores/orina , Moléculas de Adhesión Celular/orina , Venenos de Crotálidos , Hematócrito , Hemodinámica/efectos de los fármacos , Pruebas de Función Renal , Necrosis Tubular Aguda/complicaciones , Necrosis Tubular Aguda/patología , Necrosis Tubular Aguda/fisiopatología , Necrosis Tubular Aguda/orina , Lipocalina 2 , Lipocalinas/orina , Masculino , Fitoterapia , Extractos Vegetales/farmacología , Proteínas Proto-Oncogénicas/orina , Ratas , Ratas WistarRESUMEN
Four compounds (isoquercitrin, myricetin-3-O-glucoside, catechin and gallocatechin) were isolated from lyophilized aqueous extract of Schizolobium parahyba leaves by chromatography on Sephadex LH-20, followed by semipreparative HPLC using a C-18 column, and identified by 1H and 13C NMR. The compounds were then, tested against hemorrhagic and fibrinogenolytic activities of Bothrops crude venoms and isolated metalloproteinases. The inhibitors neutralized the biological and enzymatic activities of Bothrops venoms and toxins isolated from B. jararacussu and B. neuwiedi venoms. The results showed that gallocatechin and myricetin-3-O-glucoside are good inhibitors of hemorrhagic and fibrinogenolytic activities of metalloproteinases, respectively. Gallocatechin also inhibited the myotoxic activity of both B. alternatus venom and BnSP-6 (Lys49 PhospholipaseA2 from B. neuwiedi). Circular dichroism and docking simulation studies were performed in order to investigate the possible interaction between BnSP-6 and gallocatechin. This is the first time these compounds and their anti-ophidian properties are reported for S. parahyba species. Forthcoming studies involving X-ray co-crystallization, will be of great importance for the development of new therapeutic agents for the treatment of ophidian accidents and for the better understanding of the structure/function relationship of venom toxins.
Asunto(s)
Antivenenos/farmacología , Bothrops/fisiología , Venenos de Crotálidos/antagonistas & inhibidores , Fabaceae/química , Flavonoides/farmacología , Hemorragia/tratamiento farmacológico , Metaloproteasas/antagonistas & inhibidores , Inhibidores de Fosfolipasa A2 , Mordeduras de Serpientes , Animales , Antivenenos/química , Antivenenos/aislamiento & purificación , Cromatografía de Afinidad , Cromatografía Líquida de Alta Presión , Dicroismo Circular , Venenos de Crotálidos/química , Venenos de Crotálidos/enzimología , Venenos de Crotálidos/aislamiento & purificación , Venenos de Crotálidos/toxicidad , Fibrinolíticos/química , Fibrinolíticos/aislamiento & purificación , Fibrinolíticos/toxicidad , Flavonoides/química , Flavonoides/aislamiento & purificación , Hemorragia/patología , Hemorragia/prevención & control , Espectroscopía de Resonancia Magnética , Masculino , Metaloproteasas/química , Metaloproteasas/aislamiento & purificación , Metaloproteasas/toxicidad , Ratones , Modelos Moleculares , Músculos/efectos de los fármacos , Músculos/patología , Fosfolipasas A2/química , Fosfolipasas A2/aislamiento & purificación , Fosfolipasas A2/toxicidad , Extractos Vegetales/química , Extractos Vegetales/aislamiento & purificación , Extractos Vegetales/farmacología , Hojas de la Planta/químicaRESUMEN
The herbal extract of Schizolobium parahyba leaves is used commonly in the Brazil central region to treat snakebites. This study evaluates the acute toxicological effects of Schizolobium parahyba aqueous extract in mice 24 h after intraperitoneal administration. Acute toxicity was evaluated using biochemical, hematological and histopathological assays. Alterations in the levels of transaminases, bilirubin, albumin and prothrombrin time were observed, and these are likely to occur due to hepatic injury, which was confirmed by light microscopy. Liver histopathological analysis revealed the presence of lymph plasmocitary inflammatory infiltrate, but no other histopathological alterations were observed in any of the other organs analysed. The data confirm the low toxicity of the extract of Schizolobium parahyba and provide a model for the selection of a dose that does not cause injuries in the organism.
Asunto(s)
Fabaceae/toxicidad , Extractos Vegetales/toxicidad , Albúminas/análisis , Animales , Bilirrubina/sangre , Glucemia , Creatinina/sangre , Riñón/fisiopatología , Hígado/patología , Masculino , Ratones , Hojas de la Planta/química , Hojas de la Planta/toxicidad , Pruebas de Toxicidad AgudaRESUMEN
The aqueous extract prepared from Schizolobium parahyba (Sp) leaves, a native plant from Atlantic Forest (Brazil), was tested to analyse its ability to inhibit some biological and enzymatic activities induced by Bothrops alternatus (BaltCV) and Bothrops moojeni (BmooCV) snake venoms. Sp inhibited 100% of lethality, blood incoagulability, haemorrhagic and indirect haemolytic activities at a 1:10 ratio (venom/extract, w/w), as well as coagulant activity at a 1:5 ratio (venom/extract, w/w) induced by both venoms. BaltCV fibrinogenolytic activity was also neutralized by Sp at a 1:10 ratio, resulting in total protection of fibrinogen Bbeta chain and partial protection of Aalpha chain. Interaction tests have demonstrated that, at certain extract/proteins ratios, Sp precipitates proteins non-specifically suggesting the presence of tannins, which are very likely responsible for the excellent inhibiting effects of the analysed ophidian activities. Sp aqueous extract chromatography on Sephadex LH-20 was carried out aiming at the separation of these compounds that mask the obtained results. Thus, the fractionation of Sp resulted in three fractions: F1 (methanolic fraction); F2 (methanol:water fraction, 1:1 v/v); and F3 (aqueous fraction). These fractions were analysed for their ability to inhibit the BaltCV fibrinogenolytic activity. F1 inhibited 100% the venom fibrinogenolytic activity without presenting protein precipitation effect; F2 showed only partial inhibition of this venom activity. Finally, F3 did not inhibit fibrinogen proteolysis, but presented strong protein precipitating action. We conclude that Sp aqueous extract, together with tannins, also contains other compounds that can display specific inhibitory activity against snake venom toxins.
Asunto(s)
Anticoagulantes/farmacología , Antifibrinolíticos/farmacología , Bothrops , Fabaceae/química , Venenos de Víboras/toxicidad , Animales , Anticoagulantes/química , Antifibrinolíticos/química , Coagulación Sanguínea/efectos de los fármacos , Cromatografía en Gel , Fibrinógeno/metabolismo , Hemorragia/prevención & control , Masculino , Ratones , Inhibidores de Fosfolipasa A2 , Fosfolipasas A2/metabolismo , Extractos Vegetales/química , Extractos Vegetales/farmacología , Hojas de la Planta/química , Taninos/química , Taninos/farmacología , Venenos de Víboras/antagonistas & inhibidores , Venenos de Víboras/enzimologíaRESUMEN
Many medicinal plants have been recommended for the treatment of snakebites. The aqueous extracts prepared from the leaves of Schizolobium parahyba (a plant found in Mata Atlantica in Southeastern Brazil) were assayed for their ability to inhibit some enzymatic and biological activities induced by Bothrops pauloensis and Crotalus durissus terrificus venoms as well as by their isolated toxins neuwiedase (metalloproteinase), BnSP-7 (basic Lys49 PLA(2)) and CB (PLA(2) from crotoxin complex). Phospholipase A(2), coagulant, fibrinogenolytic, hemorrhagic and myotoxic activities induced by B. pauloensis and C. d. terrificus venoms, as well as by their isolated toxins were significantly inhibited when different amounts of S. parahyba were incubated previously with these venoms and toxins before assays. However, when S. parahyba was administered at the same route as the venoms or toxins injections, the tissue local damage, such as hemorrhage and myotoxicity was only partially inhibited. The study also evaluated the inhibitory effect of S. parahyba upon the spreading of venom proteins from the injected area into the systemic circulation. The neutralization of systemic alterations induced by i.m. injection of B. pauloensis venom was evaluated by measuring platelet and plasma fibrinogen levels which were significantly maintained when S. parahyba extract inoculation occurred at the same route after B. pauloensis venom injection. In conclusion, the observations confirmed that the aqueous extract of S. parahyba possesses potent snake venom neutralizing properties. It may be used as an alternative treatment to serum therapy and as a rich source of potential inhibitors of toxins involved in several physiopathological human and animal diseases.